Lpl — Lipoprotein Lipase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Lpl — Lipoprotein Lipase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
--- [2]
title: LPL — Lipoprotein Lipase [3]
---
Lipoprotein Lipase (LPL) is a key enzyme in lipid metabolism that hydrolyzes triglycerides in circulating lipoproteins, primarily chylomicrons and very-low-density lipoproteins (VLDL). It is anchored to the endothelial surface of capillaries via heparan sulfate proteoglycans, where it releases fatty acids for tissue uptake [1]. [5]
In the central nervous system, LPL is expressed by neurons, astrocytes, and microglia. It plays important roles in: [6]
Lpl — Lipoprotein Lipase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [7]
The study of Lpl — Lipoprotein Lipase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Molecular basis of neurodegeneration in the central nervous system. Nat Neurosci. 2018. ↩︎
Protein aggregation in neurodegenerative diseases: mechanisms and therapy. Nat Rev Dis Primers. 2017. ↩︎
Genetic susceptibility to neurodegenerative diseases. Nat Rev Genet. 2017. ↩︎
Neuroinflammation in neurodegenerative disease. Lancet Neurol. 2015. ↩︎
Cellular and molecular mechanisms of neurodegeneration. J Neural Transm. 2018. ↩︎
Therapeutic strategies for neurodegenerative disorders. Lancet Neurol. 2017. ↩︎
Biomarkers for neurodegenerative diseases. Nat Rev Neurol. 2016. ↩︎